Fig. 3From: Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetesPerirenal adipose tissue metabolism (Renal AT): SUV mean (A) and SUV max (B) of perirenal adipose tissue in placebo and dapagliflozin groupBack to article page